Live Breaking News & Updates on Kalvista Pharmaceuticals Daily
Stay updated with breaking news from Kalvista pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par acquired 67,546 shares of the business’s stock in a transaction on Monday, January 22nd. The shares were bought at an average cost of $12.55 per share, with a total value of $847,702.30. Following the completion of the acquisition, the insider now […] ....
KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) and Gain Therapeutics (NASDAQ:GANX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Profitability This table compares KalVista Pharmaceuticals and […] ....
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par purchased 47,700 shares of KalVista Pharmaceuticals stock in a transaction that occurred on Wednesday, January 10th. The shares were acquired at an average price of $12.67 per share, with a total value of $604,359.00. Following the acquisition, the insider now directly […] ....
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par acquired 69,184 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The shares were bought at an average price of $12.44 per share, with a total value of $860,648.96. Following the completion of the purchase, the […] ....
Insider Selling: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Insider Sells $224,045.21 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.